High Dose Vaccine
- All
- News
- Videos
-
Ministry Dismisses Reports On High Number Of 'Zero Dose Children' In India
The Union Health Ministry on Thursday said media reports stating that India has a high number of 'zero dose children', who did not receive any vaccine, in comparison to other countries based on UNICEF report.
-
US Finds Monkeypox Vaccine Highly Effective In Early Data
The monkeypox vaccine is highly effective, protecting people as early as two weeks after the first dose, the US Centers for Disease Control and Prevention said Wednesday.
-
US Monkeypox Vaccine Campaign Ramped Up, 56,000 Doses Released
US health authorities said on Tuesday they were immediately releasing 56,000 doses of monkeypox vaccine -- five times the number distributed so far -- to areas of high transmission as part of a major escalation of the country's immunization strategy.
-
Delhi High Court Refuses Plea To Reduce Gap Between Vaccine Doses
The Delhi High Court Friday refused to entertain a plea seeking direction to the authorities to reduce the gap between the second and precautionary dose of the COVID-19 vaccine from nine months to three months for frontline workers and senior citizen
-
Denmark Proposes 4th Covid Jab For "Vulnerable Citizens" Amid Omicron
The Danish government on Wednesday proposed a fourth Covid vaccine dose for highly vulnerable people, amid a spike in cases of the Omicron variant.
-
Booster Dose Protects Adults Above 65 Against Omicron Infections: UK Study
A third top-up booster dose of a COVID-19 vaccine provides high levels of protection against severe disease from the Omicron variant among older adults, a latest UK study concluded on Saturday.
-
PM's Speech Highlights: Booster Doses Announced, Vaccines For Children
The Prime Minister said that as people prepare to welcome the new year with hope and celebration, it's also a time to be careful as the highly contagious Omicron variant is rapidly pushing up Covid infections.
-
Are Booster Doses Needed? Looking Into It, Centre Tells High Court
The Centre has told the Delhi High Court that the National Technical Advisory Group of Immunization (NTAGI) and National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) are deliberating and considering scientific evidence related to the
-
Pfizer Jab Provides Less Immunity To Omicron Than Other Variants: Study
Pfizer Inc.'s vaccine provides less immunity to the omicron variant than to other major versions of Covid-19, according to laboratory experiments that still indicated a third dose may help stop the highly mutated strain.
-
Zydus Cadila's Covid Vaccine ZyCoV-D To Be Used In 7 States Initially
Zydus Cadila's Covid vaccine ZyCoV-D will initially be used in 7 states, including Maharashtra, Tamil Nadu, UP and Bengal, which have been recommended to identify the districts with a high number of people who have not received a single dose yet.
-
Delhi High Court Seeks Centre's Stand On Administering Covid Booster Shots
The Delhi High Court today directed the Centre to clarify its stand on administering booster doses to those who are fully vaccinated against coronavirus, saying it does not want a second-wave-like situation on account of being conservative.
-
Mix-And-Match Vaccines Highly Effective Against COVID-19: Lancet Study
People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study.
-
Pfizer Vaccine Highly Effective Against COVID-19 Hospitalisations For 6 Months: Lancet Study
Two doses of the Pfizer COVID-19 vaccine are 90 per cent effective against hospitalisation from the disease for all variants, including Delta, for at least six months, according to a study published in The Lancet journal on Tuesday.
-
Pfizer Vaccine Prevents Severe Covid For At Least 6 Months, Shows Study
Vaccination with two doses of the Pfizer jab stays highly effective against severe Covid -- including the Delta variant -- for at least six months, an analysis of US patients said Monday.
-
Court Notice To Centre As Cancer Patient Wants Covaxin Jab After Covishield
The Delhi High Court today sought response of the centre on a plea by a cancer patient seeking permission to take Covaxin as the second dose of vaccine as advised by the doctors, instead of Covishield which was administered to him as the first dose
-
Ministry Dismisses Reports On High Number Of 'Zero Dose Children' In India
The Union Health Ministry on Thursday said media reports stating that India has a high number of 'zero dose children', who did not receive any vaccine, in comparison to other countries based on UNICEF report.
-
US Finds Monkeypox Vaccine Highly Effective In Early Data
The monkeypox vaccine is highly effective, protecting people as early as two weeks after the first dose, the US Centers for Disease Control and Prevention said Wednesday.
-
US Monkeypox Vaccine Campaign Ramped Up, 56,000 Doses Released
US health authorities said on Tuesday they were immediately releasing 56,000 doses of monkeypox vaccine -- five times the number distributed so far -- to areas of high transmission as part of a major escalation of the country's immunization strategy.
-
Delhi High Court Refuses Plea To Reduce Gap Between Vaccine Doses
The Delhi High Court Friday refused to entertain a plea seeking direction to the authorities to reduce the gap between the second and precautionary dose of the COVID-19 vaccine from nine months to three months for frontline workers and senior citizen
-
Denmark Proposes 4th Covid Jab For "Vulnerable Citizens" Amid Omicron
The Danish government on Wednesday proposed a fourth Covid vaccine dose for highly vulnerable people, amid a spike in cases of the Omicron variant.
-
Booster Dose Protects Adults Above 65 Against Omicron Infections: UK Study
A third top-up booster dose of a COVID-19 vaccine provides high levels of protection against severe disease from the Omicron variant among older adults, a latest UK study concluded on Saturday.
-
PM's Speech Highlights: Booster Doses Announced, Vaccines For Children
The Prime Minister said that as people prepare to welcome the new year with hope and celebration, it's also a time to be careful as the highly contagious Omicron variant is rapidly pushing up Covid infections.
-
Are Booster Doses Needed? Looking Into It, Centre Tells High Court
The Centre has told the Delhi High Court that the National Technical Advisory Group of Immunization (NTAGI) and National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) are deliberating and considering scientific evidence related to the
-
Pfizer Jab Provides Less Immunity To Omicron Than Other Variants: Study
Pfizer Inc.'s vaccine provides less immunity to the omicron variant than to other major versions of Covid-19, according to laboratory experiments that still indicated a third dose may help stop the highly mutated strain.
-
Zydus Cadila's Covid Vaccine ZyCoV-D To Be Used In 7 States Initially
Zydus Cadila's Covid vaccine ZyCoV-D will initially be used in 7 states, including Maharashtra, Tamil Nadu, UP and Bengal, which have been recommended to identify the districts with a high number of people who have not received a single dose yet.
-
Delhi High Court Seeks Centre's Stand On Administering Covid Booster Shots
The Delhi High Court today directed the Centre to clarify its stand on administering booster doses to those who are fully vaccinated against coronavirus, saying it does not want a second-wave-like situation on account of being conservative.
-
Mix-And-Match Vaccines Highly Effective Against COVID-19: Lancet Study
People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study.
-
Pfizer Vaccine Highly Effective Against COVID-19 Hospitalisations For 6 Months: Lancet Study
Two doses of the Pfizer COVID-19 vaccine are 90 per cent effective against hospitalisation from the disease for all variants, including Delta, for at least six months, according to a study published in The Lancet journal on Tuesday.
-
Pfizer Vaccine Prevents Severe Covid For At Least 6 Months, Shows Study
Vaccination with two doses of the Pfizer jab stays highly effective against severe Covid -- including the Delta variant -- for at least six months, an analysis of US patients said Monday.
-
Court Notice To Centre As Cancer Patient Wants Covaxin Jab After Covishield
The Delhi High Court today sought response of the centre on a plea by a cancer patient seeking permission to take Covaxin as the second dose of vaccine as advised by the doctors, instead of Covishield which was administered to him as the first dose
